Related Experiment Video
Updated: Nov 10, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for
Hanyu Zhang1,2, Mingxing Li1,2, Parham Jabbarzadeh Kaboli1,2
1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, PR China.
Background:
Cluster of differentiation molecules are markers of immune cells that have been identified as a potential immunotherapeutic target for cancer treatment. MicroRNAs are small non-coding RNAs that act as tumor suppressors or oncogenes whose importance in diagnosis, prognosis, and treatment of gastric and colorectal cancers has been widely reported. However, their association with cluster of differentiation molecules in gastrointestinal cancers has not been well studied. Therefore, our study aimed to analyze the relationship between microRNAs and cluster of differentiation molecules in gastrointestinal cancers, and to identify cluster of differentiation molecule-associated microRNAs as prognostic biomarkers for gastrointestinal cancer patients.
Methods:
Targetscan, Starbase, DIANA microT, and miRDB were used to investigate microRNA profiles that might be correlated with cluster of differentiation molecules in gastrointestinal cancers. Moreover, The Cancer Genome Atlas data analysis was used to investigate the association between cluster of differentiation molecules and microRNA expression in patients with gastric, colon, rectal, pancreatic, and esophageal cancers. The Kaplan-Meier plotter was used to identify the association between overall survival and cluster of differentiation molecule-associated microRNA expression in gastrointestinal cancer patients.
Results:
miR-200a, miR-559, and miR-1236 were negatively associated with CD86, CD81, and CD160, respectively, in almost all types of gastrointestinal cancers, which were further verified in the in vitro studies by transfecting microRNA mimics in gastric cancer, colon cancer, pancreatic, and esophageal cell lines.
Conclusion:
Our study showed that miR-200a, miR-1236, and miR-559 are identified as cluster of differentiation-associated microRNAs in gastrointestinal cancers, providing a novel perspective to identify new therapeutic targets for cancer immunotherapy in gastrointestinal cancer patients.
Insights
This study identifies specific microRNAs (miR-200a, miR-559, miR-1236) associated with cluster of differentiation molecules in gastrointestinal cancers. These findings offer potential new biomarkers for cancer immunotherapy and patient prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Cluster of differentiation (CD) molecules are immune cell markers and potential cancer immunotherapy targets.
- MicroRNAs (miRNAs) are crucial in cancer, but their link with CD molecules in gastrointestinal (GI) cancers is underexplored.
- Understanding miRNA-CD molecule interactions may reveal new prognostic and therapeutic strategies for GI cancers.
Purpose of the Study:
- To investigate the relationship between microRNAs and cluster of differentiation molecules in various gastrointestinal cancers.
- To identify specific microRNAs associated with CD molecules as potential prognostic biomarkers.
- To explore novel therapeutic targets for gastrointestinal cancer immunotherapy.
Main Methods:
- Utilized bioinformatics tools (Targetscan, Starbase, DIANA microT, miRDB) to predict miRNA-CD molecule correlations.
- Analyzed The Cancer Genome Atlas (TCGA) data for miRNA and CD molecule expression in gastric, colon, rectal, pancreatic, and esophageal cancers.
- Employed Kaplan-Meier analysis to assess the association between CD molecule-associated miRNA expression and overall survival.
Main Results:
- Identified negative associations between miR-200a/CD86, miR-559/CD81, and miR-1236/CD160 across multiple GI cancer types.
- Validated these miRNA-CD molecule associations in vitro using miRNA mimics in relevant cancer cell lines (gastric, colon, pancreatic, esophageal).
Conclusions:
- miR-200a, miR-559, and miR-1236 are confirmed as cluster of differentiation-associated microRNAs in gastrointestinal cancers.
- These miRNAs represent novel targets for cancer immunotherapy and potential prognostic biomarkers in GI cancer patients.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
MicroRNAs
MicroRNAs

